FY2024 Earnings Estimate for ISRG Issued By Leerink Partnrs

Intuitive Surgical, Inc. (NASDAQ:ISRG) – Research analysts at Leerink Partnrs dropped their FY2024 earnings estimates for shares of Intuitive Surgical in a research report issued on Tuesday, October 15th. Leerink Partnrs analyst M. Kratky now anticipates that the medical equipment provider will post earnings of $5.22 per share for the year, down from their prior estimate of $5.23. The consensus estimate for Intuitive Surgical’s current full-year earnings is $5.22 per share. Leerink Partnrs also issued estimates for Intuitive Surgical’s FY2025 earnings at $6.16 EPS.

Several other research firms have also weighed in on ISRG. JPMorgan Chase & Co. lifted their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Wells Fargo & Company boosted their target price on Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research note on Friday. Stifel Nicolaus boosted their price target on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a report on Friday. Piper Sandler reissued an “overweight” rating and set a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a research report on Friday. Finally, Morgan Stanley upped their price objective on Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research note on Monday, July 15th. One analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $503.75.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $521.15 on Friday. The company has a market capitalization of $184.85 billion, a price-to-earnings ratio of 94.07, a P/E/G ratio of 5.40 and a beta of 1.39. The business’s 50-day moving average is $483.85 and its 200-day moving average is $437.79. Intuitive Surgical has a 1 year low of $254.85 and a 1 year high of $523.34.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. The business had revenue of $2.01 billion for the quarter, compared to analysts’ expectations of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The business’s quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.18 earnings per share.

Insider Activity at Intuitive Surgical

In other news, Director Craig H. Barratt sold 1,400 shares of Intuitive Surgical stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total transaction of $641,382.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the sale, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at $1,461,006.84. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Craig H. Barratt sold 1,400 shares of the business’s stock in a transaction dated Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total value of $641,382.00. The disclosure for this sale can be found here. Insiders have sold 53,120 shares of company stock valued at $25,528,753 over the last three months. 0.90% of the stock is owned by corporate insiders.

Institutional Trading of Intuitive Surgical

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Resonant Capital Advisors LLC increased its position in shares of Intuitive Surgical by 8.5% in the third quarter. Resonant Capital Advisors LLC now owns 1,526 shares of the medical equipment provider’s stock valued at $750,000 after acquiring an additional 119 shares during the period. Veracity Capital LLC lifted its holdings in Intuitive Surgical by 6.4% in the 3rd quarter. Veracity Capital LLC now owns 598 shares of the medical equipment provider’s stock worth $294,000 after buying an additional 36 shares during the period. McBroom & Associates LLC grew its position in shares of Intuitive Surgical by 0.7% in the 3rd quarter. McBroom & Associates LLC now owns 18,540 shares of the medical equipment provider’s stock worth $9,108,000 after buying an additional 132 shares during the last quarter. Warren Street Wealth Advisors LLC purchased a new position in shares of Intuitive Surgical during the third quarter valued at approximately $225,000. Finally, Whitaker Myers Wealth Managers LTD. raised its holdings in shares of Intuitive Surgical by 5.6% during the third quarter. Whitaker Myers Wealth Managers LTD. now owns 965 shares of the medical equipment provider’s stock valued at $474,000 after acquiring an additional 51 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.